Media coverage
94
Media coverage
Title Pds Biotech Announces Acceptance Of Abstract On Combination Of Pds0301 With Docetaxel In Metastatic Prostate Cancer For Oral Presentation By The National Cancer Institute At Cytokines 2023 Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 17/07/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=68R1-MTR1-JBR8-B2J5-00000-00 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Street Insider Country/Territory United States Date 17/07/23 URL https://www.streetinsider.com/Press+Releases/PDS+Biotech+Announces+Acceptance+of+Abstract+on+Combination+of+PDS0301+with+Docetaxel+in+Metastatic+Prostate+Cancer+for+Oral+Presentation+by+the+National+Cancer+Institute+at+Cytokines+2023/21912832.html Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet BioSpace Country/Territory United States Date 17/07/23 URL https://www.biospace.com/article/releases/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023-/ Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet InvestorsObserver Country/Territory United States Date 17/07/23 URL https://www.investorsobserver.com/news/qm-pr/8097563597014518 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet ADVFN UK Country/Territory United Kingdom Date 17/07/23 URL https://uk.advfn.com/stock-market/NASDAQ/PDSB/share-news/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Co/91583554 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Yahoo! Finance Country/Territory United States Date 17/07/23 URL https://finance.yahoo.com/news/pds-biotech-announces-acceptance-abstract-120000760.html Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Stockwatch Country/Territory Canada Date 17/07/23 URL www.stockwatch.com/News/Item/U-z8874772-U!PDSB-20230717/U/PDSB Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023; First clinical study of immunocytokine with docetaxel in prostate Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 17/07/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=68R1-CB51-JDPV-B02G-00000-00 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet Port Arthur News Country/Territory United States Date 17/07/23 URL https://smb.panews.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet Jessamine Journal Country/Territory United States Date 17/07/23 URL https://smb.jessaminejournal.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet Times of San Diego Country/Territory United States Date 17/07/23 URL https://pr.timesofsandiego.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet TheTidewaterNews.com Country/Territory United States Date 17/07/23 URL https://smb.thetidewaternews.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet L' Observateur Country/Territory United States Date 17/07/23 URL https://smb.lobservateur.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet Winchester Sun Country/Territory United States Date 17/07/23 URL https://smb.winchestersun.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet MillisMedway - Local Town Pages Country/Territory United States Date 17/07/23 URL https://pr.millismedwaynews.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet BluegrassLive.com Country/Territory United States Date 17/07/23 URL https://smb.bluegrasslive.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet Holliston - Local Town Pages Country/Territory United States Date 17/07/23 URL https://pr.hollistontownnews.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet Kenbridge Victoria Dispatch Country/Territory United States Date 17/07/23 URL https://smb.kenbridgevictoriadispatch.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet Elizabethton.com Country/Territory United States Date 17/07/23 URL https://smb.elizabethton.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet Luverne Journal Country/Territory United States Date 17/07/23 URL https://smb.luvernejournal.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by Media name/outlet Leesville Leader Country/Territory United States Date 17/07/23 URL https://smb.theleesvilleleader.com/article/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytokines-2023?storyId=64b52dde41d6e2be8d5c5a35 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WWLP.com Country/Territory United States Date 17/07/23 URL https://www.wwlp.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WTen.com Country/Territory United States Date 17/07/23 URL https://www.news10.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WIAT TV Country/Territory United States Date 17/07/23 URL https://www.cbs42.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet MyPanhandle.com Country/Territory United States Date 17/07/23 URL https://www.mypanhandle.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Valleycentral.com Country/Territory United States Date 17/07/23 URL https://www.valleycentral.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet KOIN Country/Territory United States Date 17/07/23 URL https://www.koin.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet My Champlain Valley Country/Territory United States Date 17/07/23 URL https://www.mychamplainvalley.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WKRG Country/Territory United States Date 17/07/23 URL https://www.wkrg.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WCIA.com Country/Territory United States Date 17/07/23 URL https://www.wcia.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Texomashomepage.com Country/Territory United States Date 17/07/23 URL https://www.texomashomepage.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WJTV.com Country/Territory United States Date 17/07/23 URL https://www.wjtv.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WTWO Country/Territory United States Date 17/07/23 URL https://www.mywabashvalley.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet KTSM.com Country/Territory United States Date 17/07/23 URL https://www.ktsm.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WSAV Country/Territory Georgia Date 17/07/23 URL https://www.wsav.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet KSN Country/Territory United States Date 17/07/23 URL https://www.ksn.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WIVB Country/Territory United States Date 17/07/23 URL https://www.wivb.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Wavy Country/Territory United States Date 17/07/23 URL https://www.wavy.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WANE-TV Country/Territory United States Date 17/07/23 URL https://www.wane.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WSPA.com Country/Territory United States Date 17/07/23 URL https://www.wspa.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WGN-TV Country/Territory United States Date 17/07/23 URL https://wgntv.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WYTV News Country/Territory United States Date 17/07/23 URL https://www.wytv.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Fox 4 WDAF TV Country/Territory United States Date 17/07/23 URL https://fox4kc.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WBTW News13 Country/Territory United States Date 17/07/23 URL https://www.wbtw.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Kark.com Country/Territory United States Date 17/07/23 URL https://www.kark.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WYOU Country/Territory United States Date 17/07/23 URL https://www.pahomepage.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet NBC4 Columbus Country/Territory United States Date 17/07/23 URL https://www.nbc4i.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet KLFY Country/Territory United States Date 17/07/23 URL https://www.klfy.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet FOX21News.com Country/Territory United States Date 17/07/23 URL https://www.fox21news.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet OzarksFirst.com Country/Territory United States Date 17/07/23 URL https://www.ozarksfirst.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WKRN Country/Territory United States Date 17/07/23 URL https://www.wkrn.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WJHL.com Country/Territory United States Date 17/07/23 URL https://www.wjhl.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet KHON 2 Country/Territory United States Date 17/07/23 URL https://www.khon2.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet KRQE Country/Territory United States Date 17/07/23 URL https://www.krqe.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WNTZ Country/Territory United States Date 17/07/23 URL https://www.cenlanow.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet FOX 59 Country/Territory United States Date 17/07/23 URL https://fox59.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WYZZ-TV Country/Territory United States Date 17/07/23 URL https://www.centralillinoisproud.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WDHN Country/Territory United States Date 17/07/23 URL https://www.wdhn.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WNCT Country/Territory United States Date 17/07/23 URL https://www.wnct.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Fox8 Country/Territory United States Date 17/07/23 URL https://fox8.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WPHL-TV Country/Territory United States Date 17/07/23 URL https://phl17.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WLNS Country/Territory United States Date 17/07/23 URL https://www.wlns.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WRBL-TV Country/Territory Georgia Date 17/07/23 URL https://www.wrbl.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WBOY Country/Territory United States Date 17/07/23 URL https://www.wboy.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet KSNT TV Country/Territory United States Date 17/07/23 URL https://www.ksnt.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet BizWire Express Country/Territory India Date 17/07/23 URL https://www.bizwireexpress.com/showstoryGNW.php?storyid=639622 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet MyStateLine.com Country/Territory United States Date 17/07/23 URL https://www.mystateline.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WJBF-TV Country/Territory Georgia Date 17/07/23 URL https://www.wjbf.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet FOX5 San Diego Country/Territory United States Date 17/07/23 URL https://fox5sandiego.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet ConchoValleyHomepage.com Country/Territory United States Date 17/07/23 URL https://www.conchovalleyhomepage.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet CNYHomepage.com Country/Territory United States Date 17/07/23 URL https://www.cnyhomepage.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WVNS Country/Territory United States Date 17/07/23 URL https://www.wvnstv.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Fox40 KTXL Country/Territory United States Date 17/07/23 URL https://fox40.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WKBN 27 First News Country/Territory United States Date 17/07/23 URL https://www.wkbn.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Everything Lubbock Country/Territory United States Date 17/07/23 URL https://www.everythinglubbock.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet KELOLAND TV Country/Territory United States Date 17/07/23 URL https://www.keloland.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Siouxland Matters Country/Territory United States Date 17/07/23 URL https://www.siouxlandproud.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WRIC TV Country/Territory United States Date 17/07/23 URL https://www.wric.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WeAreGreenBay.com Country/Territory United States Date 17/07/23 URL https://www.wearegreenbay.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WesternSlopeNow.com Country/Territory United States Date 17/07/23 URL https://www.westernslopenow.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet KGET Country/Territory United States Date 17/07/23 URL https://www.kget.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet 8 News Now Country/Territory United States Date 17/07/23 URL https://www.8newsnow.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Binghamton Homepage Country/Territory United States Date 17/07/23 URL https://www.binghamtonhomepage.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet YOUR BASIN Country/Territory United States Date 17/07/23 URL https://www.yourbasin.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WPRI Country/Territory United States Date 17/07/23 URL https://www.wpri.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Myarklamiss.com Country/Territory United States Date 17/07/23 URL https://www.myarklamiss.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WFXRTV.com Country/Territory United States Date 17/07/23 URL https://www.wfxrtv.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet ABC 4 Country/Territory United States Date 17/07/23 URL https://www.abc4.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet YourCentralValley.com Country/Territory United States Date 17/07/23 URL https://www.yourcentralvalley.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet ABC 27 Country/Territory United States Date 17/07/23 URL https://www.abc27.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet WJET Country/Territory United States Date 17/07/23 URL https://www.yourerie.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet Fox 16 Country/Territory United States Date 17/07/23 URL https://www.fox16.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet KODE TV Country/Territory United States Date 17/07/23 URL https://www.fourstateshomepage.com/business/press-releases/globenewswire/8874772/pds-biotech-announces-acceptance-of-abstract-on-combination-of-pds0301-with-docetaxel-in-metastatic-prostate-cancer-for-oral-presentation-by-the-national-cancer-institute-at-cytokines-2023 Persons William Figg Title PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023 Media name/outlet GlobeNewswire Country/Territory United States Date 17/07/23 URL https://www.globenewswire.com/news-release/2023/07/17/2705600/37149/en/PDS-Biotech-Announces-Acceptance-of-Abstract-on-Combination-of-PDS0301-with-Docetaxel-in-Metastatic-Prostate-Cancer-for-Oral-Presentation-by-the-National-Cancer-Institute-at-Cytoki.html Persons William Figg